Moxisylyte
Chemical compound
- G04BE06 (WHO) C04AX10 (WHO)
- 4-[2-(Dimethylamino)ethoxy]-5-isopropyl-2-methylphenyl acetate
- 54-32-0
Y
- 4260
- DB09205 Y
- 4110
- PW8QYA7KI0
- D08239 Y
- DTXSID4023339
- Interactive image
- CC1=CC(=C(C=C1OC(=O)C)C(C)C)OCCN(C)C
InChI
- InChI=1S/C16H25NO3/c1-11(2)14-10-15(20-13(4)18)12(3)9-16(14)19-8-7-17(5)6/h9-11H,7-8H2,1-6H3
- Key:VRYMTAVOXVTQEF-UHFFFAOYSA-N
Moxisylyte, also known as thymoxamine, is a drug used in urology for the treatment of erectile dysfunction.[1] It is an α1-adrenergic antagonist.[2] In the United Kingdom, Moxisylte is marketed as Opilon (Archimedes Pharma UK Ltd) and is used for the short-term treatment of primary Raynaud's syndrome. This is a condition where the fingers and toes become discoloured and is triggered by responses to cold, or emotional distress. Opilon tablets help by improving blood circulation to the extremities.[3][4]
References
- ^ British National Formulary 69, Chapter2.6.4, page 142
- ^ Sakakibara R, Hattori T, Uchiyama T, et al. (March 2000). "Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte". J. Auton. Nerv. Syst. 79 (2–3): 191–5. doi:10.1016/S0165-1838(99)00105-8. PMID 10699651.
- ^ British National Formulary 70, page 205
- ^ "Opilon tablets - Patient Information Leaflet (PIL) - (eMC)". www.medicines.org.uk.
- v
- t
- e
Peripheral vasodilators (C04)
- Non-selective
- Selective α1-blockers
 | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
 | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
